James R. Gillette
- Pharmacology top 0.01%
- Molecular Biology top 1%
- Oncology top 1%
- Biochemistry top 0.1%
- Plant Science top 1%
- Co-authors
- David J. JollowNicola ZampaglioneJohn R. MitchellB.B. BrodieJ.R. MitchellHènry A. SasameWilliam Z. PotterRyuichi Kato
- Topics
- Pharmacogenetics and Drug Metabolism (82 papers)Metabolism and Genetic Disorders (28 papers)Drug Transport and Resistance Mechanisms (27 papers)
- Partner nations
- United StatesSwedenCzechia
In The Last Decade
James R. Gillette
182 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pharmacology 7.8k
- Molecular Biology 4.0k
- Oncology 2.7k
- Biochemistry 1.6k
- Plant Science 1.4k
Countries citing papers authored by James R. Gillette
This map shows the geographic impact of James R. Gillette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Gillette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Gillette more than expected).
Fields of papers citing papers by James R. Gillette
This network shows the impact of papers produced by James R. Gillette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Gillette. The network helps show where James R. Gillette may publish in the future.
Co-authorship network of co-authors of James R. Gillette
This figure shows the co-authorship network connecting the top 25 collaborators of James R. Gillette. A scholar is included among the top collaborators of James R. Gillette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. Gillette. James R. Gillette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 1 | |
| 5 | 27 | |
| 6 | 11 | |
| 7 | 42 | |
| 8 | 5 | |
| 9 | 124 | |
| 10 | 19 | |
| 11 | 5 | |
| 12 | 33 | |
| 13 | Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. | 130 |
| 14 | 59 | |
| 15 | 34 | |
| 16 | 42 | |
| 17 | Microsomes and drug oxidationbreakdown → | 290 |
| 18 | 42 | |
| 19 | 285 | |
| 20 | 88 |
About James R. Gillette
James R. Gillette is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 184 papers that have together received 14.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (82 papers), Metabolism and Genetic Disorders (28 papers) and Drug Transport and Resistance Mechanisms (27 papers). The work is most often cited by research in Pharmacology (7.8k citations), Biochemistry (1.6k citations) and Clinical Biochemistry (1.0k citations). James R. Gillette has collaborated with scholars based in United States, Sweden and Czechia. Frequent co-authors include David J. Jollow, Nicola Zampaglione, John R. Mitchell, B.B. Brodie, J.R. Mitchell, Hènry A. Sasame, William Z. Potter, Ryuichi Kato, Philippe L. Gigon and Theodore E. Gram. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.